Trial · NCT05336175
Registered outcomes42
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 42
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Baseline Blood Biomarkers - Neurology 4-Pleax A, pTau-181, and pTau 231 as measured by the Quanterix Simoa Neurology 4-plex A and Simoa pTau-181 and 283 advantage kits | These measurements will be taken at baseline | We will use the Quanterix Simoa Neurology 4-Plex A (N4PA) Advantage kit to measure Neurology 4-Plex A (GFAP, NF-light, Total Tau, UCH-L1 and the Simoa pTau-181 and 283 Advantage kits to measure pTau-181 and pTau 231. |
| Primary | Baseline evaluations of associative, verbal memory as measured by the verbal paired associates task (version 2) | These measurements will be taken at baseline | The verbal paired associates task (version 2) will be used to evaluate associative, verbal memory. Scores can range from 0 to 36 with higher scores indicating better outcomes. |
| Primary | Baseline evaluations of associative, visual memory as measured by the Face Name Associative Memory Test | These measurements will be taken at baseline | The Face Name Associative Memory Test will be used to evaluate associative, visual memory. Scores can range from 0 to 12 with higher scores indicating better outcomes. |
| Primary | Baseline evaluations of pattern separation memory as measured by the Mnemonic Similarity Task | These measurements will be taken at baseline | The Mnemonic Similarity Task will be used to evaluate pattern separation memory. Scores can range from 0 to 1.0 with higher scores indicating better outcomes |
| Primary | Baseline evaluations of executive functions - updating/working memory as measured by the Keep Track Task | These measurements will be taken at baseline | The Keep Track Task will be used to evaluate executive function - updating/working memory. Scores can range from 0 to 30 with higher scores indicating better performance. |
| Primary | Baseline evaluations of executive functions - switching as measured by the Number-Letter Task | These measurements will be taken at baseline | The Number-Letter task will be used to evaluate executive function - switching. Scores can range from 0.2sec to 10 sec with higher scores indicating worse outcomes |
| Primary | Baseline evaluations of executive functions - attention/inhibition as measured by the Flanker Task | These measurements will be taken at baseline | The Flanker Task will be used to evaluate executive function - attention/inhibition. Scores can range from 200ms - 2000ms with higher scores indicating worse outcomes |
| Primary | Baseline evaluations of processing speeds - simple/complex processing speeds as measured by the Deary-Liewald Reaction Time Task | These measurements will be taken at baseline | The Deary-Liewald Reaction Time Task will evaluate processing speed - simple/complex processing speed. Scores can range from 200ms - 1500ms with higher scores indicating worse outcomes |
| Primary | Baseline evaluations of reading ability/vocabulary as measured by the North American Reading Test | These measurements will be taken at baseline | The North American Reading Test will be used to evaluate reading ability/vocabulary. Scores can range from 0 to 61 with higher score indicating better outcomes |
| Primary | Baseline evaluations of global cognitive functioning as measured by the Montreal Cognitive Assessment | These measurements will be taken at baseline | The Montreal Cognitive Assessment will be used to evaluate global cognitive functioning/ Scores can range from 0 - 30 with higher scores indicating better outcomes. |
| Primary | Participants sleep quality will be assessed as measured by the Pittsburgh Sleep Quality Index | These measurements will be taken at baseline | The Pittsburgh Sleep Quality Index will be used to assess sleep quality. Scores can range from 0 to 21 with higher scores indicating worse outcomes |
| Primary | Participants quality of life will be assessed as measured by the World Health Organization Quality of Life - BREF (WHOQOL-BREF) | These measurements will be taken at baseline | The World Health Organization Quality of Life - BREF (WHOQOL-BREF) will be used to assess participant's quality of life. Score can range from 3 to 40 with higher scores indicating better outcomes |
| Primary | Participants disability due to health/mental health conditions will be assessed as measured by the World Health Organization Disability Assessment Schedule 2.0 | These measurements will be taken at baseline | The World Health Organization Disability Assessment Schedule 2.0 will be used to assess participant's disability due to health/mental health conditions. Scores can range from 7 to 36 with higher scores indicating worse outcomes. |
| Primary | Participants physical activity will be assessed as measured by Rapid Assessment of Physical Activity | These measurements will be taken at baseline | The Rapid Assessment of Physical Activity will be used to assess participant's physical activity. Scores can range from 1 to 10 with higher scores indicating better outcomes. |
| Primary | Participants heart failure health status will be assessed as measured by the Kansas City Cardiomyopathy Questionnaire | These measurements will be taken at baseline | The Kansas City Cardiomyopathy Questionnaire. Scores can range from 12 to 118 with higher scores indicating better outcomes |
| Primary | Participants independent living skills will be assessed as measured by the Lawton-Brody Instrumental Activities of Daily Living Scale (I.A.D.L) | These measurements will be taken at baseline | The Lawton-Brody Instrumental Activities of Daily Living Scale (I.A.D.L). Scores can range from 0 to 8 with higher scores indicating better outcomes. |
| Primary | 12-week Blood Biomarkers - Neurology 4-Pleax A, pTau-181, and pTau 231 as measured by the Quanterix Simoa Neurology 4-plex A and Simoa pTau-181 and 283 advantage kits | These measurements will be taken after the 12 week drug course | We will use the Quanterix Simoa Neurology 4-Plex A (N4PA) Advantage kit to measure Neurology 4-Plex A (GFAP, NF-light, Total Tau, UCH-L1 and the Simoa pTau-181 and 283 Advantage kits to measure pTau-181 and pTau 231. |
| Primary | 12-week evaluations of associative, verbal memory as measured by the verbal paired associates task (version 2) | These measurements will be taken after the 12 week drug course | The verbal paired associates task (version 2) will be used to evaluate associative, verbal memory. Scores can range from 0 to 36 with higher scores indicating better outcomes. |
| Primary | 12-week evaluations of associative, visual memory as measured by the Face Name Associative Memory Test | These measurements will be taken after the 12 week drug course | The Face Name Associative Memory Test will be used to evaluate associative, visual memory. Scores can range from 0 to 12 with higher scores indicating better outcomes. |
| Primary | 12-week evaluations of pattern separation memory as measured by the Mnemonic Similarity Task | These measurements will be taken after the 12 week drug course | The Mnemonic Similarity Task will be used to evaluate pattern separation memory. Scores can range from 0 to 1.0 with higher scores indicating better outcomes |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05336175/registered